BioLineRx Ltd. (TLV:BLRX)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
2.200
+0.100 (4.76%)
May 29, 2025, 5:24 PM IDT

BioLineRx Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
4986415100309192
Upgrade
Market Cap Growth
-86.11%-79.39%314.57%-67.59%60.58%108.80%
Upgrade
Enterprise Value
287367-65126150
Upgrade
Last Close Price
0.020.060.380.140.430.55
Upgrade
PS Ratio
0.590.8124.01---
Upgrade
PB Ratio
0.631.758.720.561.462.72
Upgrade
P/TBV Ratio
1.267.80-0.982.14189.39
Upgrade
EV/Sales Ratio
0.030.8321.22---
Upgrade
Debt / Equity Ratio
0.661.120.880.240.070.35
Upgrade
Asset Turnover
0.470.560.07---
Upgrade
Inventory Turnover
2.533.63----
Upgrade
Quick Ratio
2.021.521.024.855.892.14
Upgrade
Current Ratio
2.281.761.104.875.912.15
Upgrade
Return on Equity (ROE)
-20.03%-69.11%-189.23%-41.96%-60.04%-108.36%
Upgrade
Return on Assets (ROA)
-21.98%-23.28%-38.30%-23.10%-24.07%-28.42%
Upgrade
Return on Capital (ROIC)
-35.44%-44.90%-61.08%-26.82%-30.23%-38.96%
Upgrade
Earnings Yield
-25.76%-39.26%-52.59%-87.63%-27.24%-50.16%
Upgrade
FCF Yield
-245.44%-187.02%-19.72%-92.62%-23.83%-38.78%
Upgrade
Buyback Yield / Dilution
-47.46%-24.37%-24.47%-16.75%-162.19%-72.70%
Upgrade
Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.